BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17703896)

  • 1. 10-year survival and quality of life in patients with high-risk pN0 prostate cancer following definitive radiotherapy.
    Berg A; Lilleby W; Bruland OS; Fosså SD
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1074-83. PubMed ID: 17703896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results in three-dimensional conformal radiotherapy of localized prostate cancer at moderate dose (66 Gy).
    Goldner G; Wachter S; Wachter-Gerstner N; Dieckmann K; Pötter R
    Strahlenther Onkol; 2006 Sep; 182(9):537-42. PubMed ID: 16944376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
    Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
    J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postradiotherapy 2-year prostate-specific antigen nadir as a predictor of long-term prostate cancer mortality.
    Zelefsky MJ; Shi W; Yamada Y; Kollmeier MA; Cox B; Park J; Seshan VE
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1350-6. PubMed ID: 19515504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year follow-up of health-related quality of life after intensity-modulated radiation therapy for prostate cancer.
    Namiki S; Ishidoya S; Ito A; Tochigi T; Numata I; Narazaki K; Yamada S; Takai Y; Arai Y
    Jpn J Clin Oncol; 2009 Nov; 39(11):732-8. PubMed ID: 19666904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-specific symptoms and general quality of life of patients with prostate carcinoma before and after primary three-dimensional conformal radiotherapy.
    Staff I; Salner A; Bohannon R; Panatieri P; Maljanian R
    Cancer; 2003 Dec; 98(11):2335-43. PubMed ID: 14635067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life measurement in long-term survivors and outcome following radical radiotherapy for localized prostate cancer.
    Galalae RM; Loch T; Riemer B; Rzehak P; Küchler T; Kimmig B; Kovács G
    Strahlenther Onkol; 2004 Sep; 180(9):582-9. PubMed ID: 15378189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life after intensity modulated radiation therapy for localized prostate cancer: comparison with conventional and conformal radiotherapy.
    Namiki S; Ishidoya S; Tochigi T; Kawamura S; Kuwahara M; Terai A; Yoshimura K; Numata I; Satoh M; Saito S; Takai Y; Yamada S; Arai Y
    Jpn J Clin Oncol; 2006 Apr; 36(4):224-30. PubMed ID: 16537689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer.
    Loeb S; Smith ND; Roehl KA; Catalona WJ
    Urology; 2007 Jun; 69(6):1170-5. PubMed ID: 17572209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late side effects unchanged 4-8 years after radiotherapy for prostate carcinoma: a comparison with age-matched controls.
    Fransson P; Widmark A
    Cancer; 1999 Feb; 85(3):678-88. PubMed ID: 10091741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional survey of long-term quality of life after radical perineal prostatectomy.
    Yang BK; Crisci A; Young MD; Silverstein AD; Peterson BL; Dahm P
    Urology; 2005 Jan; 65(1):120-5. PubMed ID: 15667876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definitive conformal radiotherapy for localized prostate cancer: a long-term follow-up study.
    Deichmueller CM; Wegener G; Karstens JH; Bruns F
    Anticancer Res; 2009 Jul; 29(7):2627-34. PubMed ID: 19596938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome following three-dimensional conformal/intensity-modulated external-beam radiotherapy for clinical stage T3 prostate cancer.
    Zelefsky MJ; Yamada Y; Kollmeier MA; Shippy AM; Nedelka MA
    Eur Urol; 2008 Jun; 53(6):1172-9. PubMed ID: 18222596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes.
    Zelefsky MJ; Yamada Y; Fuks Z; Zhang Z; Hunt M; Cahlon O; Park J; Shippy A
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1028-33. PubMed ID: 18280056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant hormonal therapy impairs sexual outcome among younger men who undergo external beam radiotherapy for localized prostate cancer.
    Hollenbeck BK; Wei JT; Sanda MG; Dunn RL; Sandler HM
    Urology; 2004 May; 63(5):946-50. PubMed ID: 15134986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity is not predictive of overall survival following permanent prostate brachytherapy.
    Merrick GS; Galbreath RW; Butler WM; Wallner KE; Allen ZA; Adamovich E
    Am J Clin Oncol; 2007 Dec; 30(6):588-96. PubMed ID: 18091052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy.
    Jereczek-Fossa BA; Zerini D; Vavassori A; Fodor C; Santoro L; Minissale A; Cambria R; Cattani F; Garibaldi C; Serafini F; Matei VD; de Cobelli O; Orecchia R
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):115-25. PubMed ID: 19004572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot study.
    Ares C; Popowski Y; Pampallona S; Nouet P; Dipasquale G; Bieri S; Ozsoy O; Rouzaud M; Khan H; Miralbell R
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):656-63. PubMed ID: 19250768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate brachytherapy in men > or =75 years of age.
    Merrick GS; Wallner KE; Galbreath RW; Butler WM; Brammer SG; Allen ZA; Adamovich E
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):415-20. PubMed ID: 18374514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.